Trial intelligence / Profile preview

Clopidogrel Dose Adjustment in ACS

NCT02096419Phase 4Completed

Sponsor
University of Zagreb
Start
Feb 2012
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel in acute coronary syndrome (ACS), sponsored by University of Zagreb. Started Feb 2012; status: completed.

02

Drugs

clopidogrel
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT02096419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02096419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call